Compleat DHA One
- Form
- Softgel
- Product type
- Fat / Fatty Acid
- Serving size
- 1 Pink Chewable Softgel(s)
Ingredients
Supplement Facts
- Serving size
- 1 Pink Chewable Softgel(s)
| Ingredients | Amount | %DV |
|---|---|---|
| Essential Fatty Acids | Not disclosed | — |
| Fish Oil concentrate | Not disclosed | — |
| Docosahexaenoic Acid | 135 mg | — |
| Eicosapentaenoic Acid | 33.8 mg | — |
| Other Omega-3 Fatty Acids | 71.2 mg | — |
“Not disclosed” means the manufacturer does not publish the amount — typically a component of a proprietary blend. It does not mean the amount is zero. Indented rows are components of the blend directly above them, mirroring the nesting on the label.
Show other ingredientsHide other ingredients10
Ingredients listed outside the Supplement Facts panel. Amounts and %DV are not required there, so they are not recorded.
| Ingredients | Form |
|---|---|
| highly refined and concentrated Omega-3 Fish Oil | Tuna |
| Capsule | Cochineal, Gelatin, Iron Oxide, Potato Starch, Titanium Dioxide |
| Coconut Oil | — |
| Lecithin | — |
| natural Vitamin E | d-Alpha-Tocopherol (natural) |
| Sucralose | — |
| Xylitol | Galactose, Glucose, Invert Sugar, Mannitol, Sorbitol, Sucrose |
| Citric Acid-Anyhdrous | — |
| Orange Oil | — |
| Forest Fruits flavour | — |
Source: DSLD (US NIH) label ID 37074Amounts are as stated on the product label. Check the latest label before you buy.
Where to buy
Intended for
- Adults
- Pregnant Women
- Lactating
Label directions and warnings
Quoted from the label as written. Marketing statements, such as claimed benefits, are not shown.
- Directions
- DOSAGE AND ADMINISTRATION: One chewable softgel daily or as directed by a physician.
- Precautions
- CONTRAINDICATIONS: This product is contraindicated in patients with a known hypersensitivity to any of the ingredients.
- Precautions: children
- KEEP THIS AND ALL DRUGS OUT OF THE REACH OF CHILDREN
- Precautions: pregnancy, nursing, medications
- WARNING: Ingestion of more than 3 grams of Omega-3 fatty acids (such as DHA) per day has been shown to have potential antithrombotic effects, including increased bleeding time and International Normalized Ratio (INR). Administration of Omega-3 fatty acids should be avoided in patients on anticoagulants and in those known to have an inherited or acquired predisposition to bleeding.
- Storage
- Store at controlled room temperature, 15(0)-30(0)C (59(0)-86(0)F).